Arcutis Biotherapeutics Inc (ARQT)
9.93
-0.54
(-5.16%)
USD |
NASDAQ |
Nov 14, 16:00
9.93
0.00 (0.00%)
Pre-Market: 07:58
Arcutis Biotherapeutics Cash from Investing (Quarterly): 84.78M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 84.78M |
| June 30, 2024 | -62.14M |
| March 31, 2024 | -28.70M |
| December 31, 2023 | -62.19M |
| September 30, 2023 | 45.55M |
| June 30, 2023 | 89.12M |
| March 31, 2023 | 107.75M |
| December 31, 2022 | 42.20M |
| September 30, 2022 | -197.26M |
| June 30, 2022 | 52.56M |
| March 31, 2022 | 15.30M |
| December 31, 2021 | 23.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.471M |
| June 30, 2021 | -164.92M |
| March 31, 2021 | 62.00M |
| December 31, 2020 | -75.89M |
| September 30, 2020 | -91.71M |
| June 30, 2020 | 6.105M |
| March 31, 2020 | -20.33M |
| December 31, 2019 | -36.00M |
| September 30, 2019 | 21.10M |
| June 30, 2019 | -2.152M |
| March 31, 2019 | -9.27M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-197.26M
Minimum
Sep 2022
107.75M
Maximum
Mar 2023
-10.34M
Average
4.788M
Median
Cash from Investing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -72.72M |
| Biogen Inc | -1.181B |
| Vertex Pharmaceuticals Inc | -348.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.69M |
| Cash from Financing (Quarterly) | 0.394M |
| Free Cash Flow | -167.80M |
| Free Cash Flow Per Share (Quarterly) | -0.2802 |
| Free Cash Flow to Equity (Quarterly) | -35.63M |
| Free Cash Flow to Firm (Quarterly) | -28.18M |
| Free Cash Flow Yield | -14.84% |